Search
Artelo Biosciences Inc
ARTLAdd to Watchlist
2.880USD
0.0000.00%
Market hours 10/14, 12:40（ET）
10.05MMarket Cap
LossP/E TTM
ARTL Analyst Recommendation Trends
In the current month, ARTL has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ARTL average Analyst price target in the last month is 30.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
ARTL Analyst Rating for Peer Comparison
Updated: Oct 14, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
Revolution Medicines Inc
RVMD
9
14
1
0
0
24
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
7
0
0
23
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
Forecast
--
--
--
Actual
-6.18
-4.00
-8.05
Surprise
--
--
--
FAQs
What is the analyst rating for Artelo Biosciences Inc?
Based on the ratings of Artelo Biosciences Inc's stock from 0 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.